Literature DB >> 18424057

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.

James W Russell1, Alison Berent-Spillson2, Andrea M Vincent3, Catherine L Freimann4, Kelli A Sullivan3, Eva L Feldman3.   

Abstract

Clinical studies suggest that impaired glucose tolerance (IGT) is associated with the development of neuropathy. The aim of the current study was to determine if neuropathy developed in the female Zucker Diabetic Fatty (ZDF) rat, an animal model of IGT and type 2 diabetes. The ZDF rat develops impaired glucose tolerance (IGT) when fed a control diet, and frank diabetes when fed a high fat diet. Following 10 weeks of hyperglycemia, sensory nerve action potentials (SNAP) and compound motor action potentials (CMAP) were reduced and sensory conduction velocities were slowed (distal>proximal) in the tail and hind limb in ZDF animals with IGT and frank diabetes (p<0.01). Neuropathy was coupled with evidence of increased reactive oxygen species (ROS) and cellular injury in dorsal root ganglion (DRG) neurons from IGT animals. Our study supports the hypothesis that neuropathy develops in an animal model of IGT and is associated with evidence of oxidative injury in DRG and peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424057      PMCID: PMC2453225          DOI: 10.1016/j.nbd.2008.02.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  46 in total

1.  Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy.

Authors:  Ann M Schmeichel; James D Schmelzer; Phillip A Low
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

2.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.

Authors:  J R Singleton; A G Smith; M B Bromberg
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

4.  Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration.

Authors:  Alison Berent-Spillson; James W Russell
Journal:  J Neurochem       Date:  2007-04       Impact factor: 5.372

5.  Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

Authors:  M J Stevens; I Obrosova; X Cao; C Van Huysen; D A Greene
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

6.  Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats.

Authors:  Nicola M Sayers; Lisa J Beswick; Alicia Middlemas; Nigel A Calcutt; Andrew P Mizisin; David R Tomlinson; Paul Fernyhough
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

7.  Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

Authors:  M Nagamatsu; K K Nickander; J D Schmelzer; A Raya; D A Wittrock; H Tritschler; P A Low
Journal:  Diabetes Care       Date:  1995-08       Impact factor: 19.112

8.  Lipogenesis in situ in the genetically obese Zucker fatty rat (fa/fa): role of hyperphagia and hyperinsulinaemia.

Authors:  V Godbole; D A York
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

9.  Remote neurotrophic support of epidermal nerve fibres in experimental diabetes.

Authors:  C Toth; V Brussee; D W Zochodne
Journal:  Diabetologia       Date:  2006-03-10       Impact factor: 10.122

10.  Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death.

Authors:  Andrea M Vincent; James A Olzmann; Michael Brownlee; W I Sivitz; James W Russell
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  37 in total

Review 1.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

2.  Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Authors:  Bhumsoo Kim; Lisa L McLean; Stephen S Philip; Eva L Feldman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

3.  Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity.

Authors:  Ashley L Waldron; Patricia A Schroder; Kelly L Bourgon; Jessie K Bolduc; James L Miller; Adriana D Pellegrini; Amanda L Dubois; Magdalena Blaszkiewicz; Kristy L Townsend; Sandra Rieger
Journal:  J Diabetes Complications       Date:  2017-12-06       Impact factor: 2.852

Review 4.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

5.  Impaired expression of neuronal nitric oxide synthase in the gracile nucleus is involved in neuropathic changes in Zucker Diabetic Fatty rats with and without 2,5-hexanedione intoxication.

Authors:  Sheng-Xing Ma; Richard G Peterson; Edward M Magee; Paul Lee; Wai-Nang Paul Lee; Xi-Yan Li
Journal:  Neurosci Res       Date:  2015-10-28       Impact factor: 3.304

6.  Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Mehdi Khaksari; Pirasteh Norouzi; Malihea Ahooie; Fatemeh Mahboobi
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

7.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

9.  Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Authors:  Andrea M Vincent; John M Hayes; Lisa L McLean; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

10.  Literature-based discovery of diabetes- and ROS-related targets.

Authors:  Junguk Hur; Kelli A Sullivan; Adam D Schuyler; Yu Hong; Manjusha Pande; David J States; H V Jagadish; Eva L Feldman
Journal:  BMC Med Genomics       Date:  2010-10-27       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.